Predicting human papillomavirus vaccine intentions of college-aged males: An examination of parents and son's perceptions

Journal of American College Health

Volumn 60, Issue 6, 2012, Pages 449-459

  Katz, Mira L ^a,b,c   Kam, Jennifer A ^d   Krieger, Janice L ^c   Roberto, Anthony J ^d  

^a OHIO STATE UNIVERSITY   (United States)

^b UNIVERSITY OF ILLINOIS AT URBANA CHAMPAIGN   (United States)

^c OHIO STATE UNIVERSITY   (United States)

^d ARIZONA STATE UNIVERSITY   (United States)

Author keywords

HPV vaccine; human papillomavirus (HPV); males; sexually transmitted infection

Indexed keywords

WART VIRUS VACCINE;

ADOLESCENT; ADULT; ARTICLE; ATTITUDE TO HEALTH; CHILD PARENT RELATION; CONFIDENCE INTERVAL; CROSS-SECTIONAL STUDY; DECISION MAKING; HEALTH BEHAVIOR; HEALTH SURVEY; HIGH RISK BEHAVIOR; HUMAN; MALE; MEN'S HEALTH; PAPILLOMAVIRUS INFECTION; PERCEPTION; PSYCHOLOGICAL ASPECT; SELF CONCEPT; STATISTICS; STUDENT; UNITED STATES; UNIVERSITY;

ADOLESCENT; ADULT; CONFIDENCE INTERVALS; CROSS-SECTIONAL STUDIES; DECISION MAKING; HEALTH BEHAVIOR; HEALTH KNOWLEDGE, ATTITUDES, PRACTICE; HEALTH SURVEYS; HUMANS; MALE; MEN'S HEALTH; OHIO; PAPILLOMAVIRUS INFECTIONS; PAPILLOMAVIRUS VACCINES; PARENTING; PERCEPTION; RISK-TAKING; SELF EFFICACY; STUDENTS; UNIVERSITIES; YOUNG ADULT;

EID: 84864865629     PISSN: 07448481     EISSN: 19403208     Source Type: Journal    
DOI: 10.1080/07448481.2012.673523     Document Type: Article

References (27)

1. Dunne EF, Unger ER, Sternberg M, et al. Prevalence of HPV infection among females in the United States. JAMA. 2007;297:813-819.
2. Weinstock H, Berman S, Cates W Jr. Sexually transmitted diseases among American youth: incidence and prevalence estimates, 2000. Perspect Sex Reprod Health. 2004;36:6-10.
3. FDA licensure of quadrivalent human papillomavirus vaccine (HPV4, Gardasil) for use in males and guidance from the Advisory Committee on Immunization Practices (ACIP). MMWR Morb Mortal Wkly Rep. 2010;59:630-632.
4. US Food and Drug Administration. FDA: Gardasil approved to prevent anal cancer. US Food and Drug Administration. News & Events. Available at: http://www.fda.gov/NewsEvents/Newsroom/PressAnnouncements/2010/ucm237941. htm. Published December 22, 2010. Accessed August 2011.
5. Centers for Disease Control and Prevention. Recommendations on the use of quadrivalent human papillomavirus vaccine in males-Advisory Committee on Immunization Practices (ACIP), 2011. MMWR Morb Mort Wkly Rep. 2011;60:1705-1708.
6. Palefsky JM. Human papillomavirus-related disease in men: not just a women's issue. J Adolesc Health. 2010; 46(suppl 4):S12-S19.
7. Liddon N, Hood J, Wynn BA, Markowitz LE. Acceptability of human papillomavirus vaccine for males: a review of the literature. J Adolesc Health. 2010;46:113-123.
8. Reiter PL, Brewer NT, Smith JS. Human papillomavirus knowledge and vaccine acceptability among a national sample of heterosexual men. Sex Transm Infect. 2010;86:241-246.
9. Hernandez BY, Wilkens LR, Thompson PJ, et al. Acceptability of prophylactic human papillomavirus vaccination among adult men. Hum Vaccin. 2010;6:467-475.
10. Gerend MA, Barley J. Human papillomavirus vaccine acceptability among young adult men. Sex Transm Dis. 2009;36:58-62.
11. Reiter PL, McRee AL, Kadis JA, Brewer NT. HPV vaccine and adolescent males. Vaccine. 2011;29:5595-5602.
12. Zimet GD, Rosenthal SL. HPV vaccine and males: issues and challenges. Gynecol Oncol. 2010;117:S26-S31.
13. Reiter PL, McRee AL, Gottlieb SL, et al. HPV vaccine for adolescent males: acceptability to parents post-vaccine licensure. Vaccine. 2010;28:6292-6297.
14. Ogilvie GS, Remple VP, Marra F, et al. Intention of parents to have male children vaccinated with the human papillomavirus vaccine. Sex Transm Infect. 2008;84:318-323.
15. Dempsey AF, Butchart A, Singer D, Clark S, Davis M. Factors associated with parental intentions for male human papillomavirus vaccination: results of a national survey. Sex Transm Dis. 2011;38:769-776.
16. Rimal RN, Real K. Perceived risk and efficacy beliefs as motivators of change. Use of the risk perception attitude (RPA) framework to understand health behaviors. Human Commun Res. 2003;29:370-399.
17. Witte K, Cameron KA, McKeon JK, Berkowitz JM. Predicting risk behaviors: development and validation of a diagnostic scale. J Health Commun. 1996;1:317-341.
18. Ajzen I. Perceived behavioral control, self-efficacy, locus of control, and the theory of planned behavior. J Appl Soc Psychol. 2002;32:665-683.
19. Muthen LK, Muthen BO. Mplus User's Guide. 5th ed. Los Angeles, CA: Muthen & Muthen; 2007.
20. Jackson JL, Dezee K, Douglas K, Shimeall W. Introduction to structural equation modeling (path analysis). Available at: http://sgim.org/userfiles/file/ AMHandouts/AM05/handouts/PA08.pdf. Published 2005. Accessed December 30, 2011.
21. Kenny DA, Kashy DA, Cook WL. Dyadic Data Analysis. New York, NY: The Guilford Press; 2006.
22. Hu L, Bentler PM. Cutoff criteria for fit indexes in covariance structure analysis: conventional criteria versus new alternatives. Structural Equation Modeling. 1999;6:1-55.
23. Preacher KJ, Hayes AF. Asymptotic and resampling strategies for assessing and comparing indirect effects in multiple mediator models. Behav Res Methods. 2008;40:879-891.
24. Graham JW. Missing data analysis: making it work in the real world. Annu Rev Psychol. 2009;60:549-576.
25. Daley EM, Marhefka SL, Buhi ER, Vamos CA, Hernandez ND, Giuliano AR.Human papillomavirus vaccine intentions among men participating in a human papillomavirus natural history study versus a comparison sample. Sex Transm Dis. 2010;37:644-652.
26. McRee AL, Reiter PL, Chantala K, Brewer NT. Does framing human papillomavirus vaccine as preventing cancer in men increase vaccine acceptability? Cancer Epidemiol Biomarkers Prev. 2010;19:1937-1944.
27. Krieger JL, Kam JA, Katz ML, Roberto AJ. Does mother know best? An actor-partner model of college-age females' human papillomavirus vaccination behavior. Human Commun Res. 2011;37:107-124.